COMMUNIQUÉS West-GlobeNewswire

Scene Health Appoints Lisa Ritsky-Lamb as Chief Financial Officer to Accelerate Next Phase of Growth
26/08/2026
BALTIMORE, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Scene Health, a leader in MedEngagement, today announced the appointment of Lisa Ritsky-Lamb as Chief Financial Officer (CFO). Ritsky-Lamb joins the executive leadership team [...]
JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis
26/08/2026
JAMA Dermatology publication includes results from VALOR skin-specific secondary endpoints, with rapid and durable improvements seen for brepocitinib 30 mg compared to placebo across multiple dimensions of cutaneous [...]
RAMSAY SANTE : Résultats annuels provisoires à fin juin 2026
26/08/2026
COMMUNIQUE DE PRESSE Paris, 26 août 2026 Résultats annuels provisoires à fin juin 2026 Croissance du chiffre d’affaires et discipline financière contribuent à l’amélioration de la rentabilité opérationnelle Capital [...]
RAMSAY SANTE : Provisional annual results at the end of June 2026
26/08/2026
PRESS RELEASE Paris, 26 th August 2026 Provisional annual results at the end of June 2026 Revenue growth and disciplined efficiency drive stronger operational profitability Capital Markets Day on 17 th September: Ramsay [...]
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
26/08/2026
Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEB Filings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained through approval, may [...]
Ligand to Participate in September Investor Conferences
26/08/2026
JUPITER, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced its senior management team will participate in the following upcoming investor conferences: Wells Fargo [...]
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
26/08/2026
Doses first patient at 70 mCi dose of RV-01, the first radiopharmaceutical therapeutic developed in Company’s joint venture with MD Anderson Cancer Center SYDNEY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Radiopharm [...]
Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI
26/08/2026
Partnership helps California schools and community-based organizations simplify CYBHI participation while expanding access to behavioral health services for students NEWPORT BEACH, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE [...]
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
26/08/2026
WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Wells Fargo [...]
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
26/08/2026
Professor Marlies Wijsenbeek will give an oral presentation on the quality-of-life outcomes assessed by the LCQ from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough [...]
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
26/08/2026
Photo Caption: Dr. Dongeun Yong, CEO, gives a tour of MicrobiotiX’s GMP facility, where the clinical material being used in the MP101 trial was manufactured. SEOUL, South Korea, Aug. 26, 2026 (GLOBE NEWSWIRE) -- [...]
Eikon Therapeutics to Participate in Investor Conferences in September 2026
26/08/2026
MILLBRAE, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious [...]
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
26/08/2026
- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here , which indicated treatment with acoramidis may improve cardiac structure and function with evidence of amyloid [...]
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
26/08/2026
BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients [...]
FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development
26/08/2026
SOT106 targets LRRC15, a clinically validated target broadly expressed across multiple sarcoma subtypes First-in-human study expected to begin this year, marking a key development milestone for SOT106 PRAGUE, Basel and [...]
BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy
26/08/2026
Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders [...]
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
26/08/2026
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities Blair, Nebraska, Aug. 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. biotechnology sector [...]
CoreHealth Technologies Acquires Konnected to Expand Wellness Expertise and Program Delivery Capabilities
26/08/2026
TORONTO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- CoreHealth Technologies, a leading provider of configurable wellness technology and health assessment solutions, today announced the acquisition of Konnected Workplace Wellness [...]
Curonix LLC Appoints Healthcare and Financial Services Veteran Carlos A. Migoya to Board of Managers
26/08/2026
POMPANO BEACH, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the appointment of Carlos A. Migoya to its Board of Managers [...]

Pages